{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T03:53:54Z","timestamp":1768967634044,"version":"3.49.0"},"reference-count":39,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,9,11]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"\n Objectives<\/jats:title>\n This study was conducted to examine urban\u2013rural differences in the real-world prescribing pattern of oral anticoagulants and geographic variations in the prescribing pattern among clinicians serving Medicare beneficiaries in the USA.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n A cross-sectional study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n A real-world setting.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n 232 665 clinicians who prescribed oral anticoagulants for Medicare beneficiaries from the 2020 Medicare Provider Utilisation and Payment Data were classified as warfarin only, direct oral anticoagulants (DOACs) only or warfarin+DOAC prescribers.<\/jats:p>\n <\/jats:sec>\n \n Main outcome measures<\/jats:title>\n Urban\u2013rural differences in the prescribing patterns were examined using multivariate multinominal logistic regression analysis. A geospatial analysis was conducted to estimate standardised prescriber ratios (SPR) for DOAC only or warfarin only prescribers versus warfarin+DOAC prescribers to illustrate hot and cold spots for DOAC adoption in the USA.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n 92% of clinicians who prescribed oral anticoagulants prescribed DOAC in 2020. Clinicians from rural regions were more likely to prescribe warfarin only (adjusted OR=1.335, 95% CI=(1.281 to 1.391)) and DOAC only (adjusted OR=2.052, 95% CI=(1.999 to 2.106)), compared with clinicians from urban regions. Hot spots for SPR of DOAC only versus warfarin+DOAC prescribers were mostly found in California, southern and southeastern states; cold spots were mostly found in Minnesota and Iowa. Hot spots for SPR of warfarin only versus warfarin+DOAC prescribers were mostly found in several metropolitan areas on the west coast and in Midwest; cold spots were mostly found on the east coast.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Urban\u2013rural status of clinicians was associated with their prescribing patterns of oral anticoagulants. The study identifies geographical heterogeneity in DOAC adoption and highlights gaps that may need to be addressed for increased accessibility of DOAC for patients in need.<\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081628","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T22:50:20Z","timestamp":1727304620000},"page":"e081628","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Disparities in the real-world prescription pattern of oral anticoagulants for US Medicare beneficiaries: a geospatial analysis"],"prefix":"10.1136","volume":"14","author":[{"given":"Jingrui","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Scientific Affairs, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Liang","sequence":"additional","affiliation":[{"name":"Chesapeake Biological Laboratory, University of Maryland Center for Environmental Science, Solomons, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6546-9830","authenticated-orcid":false,"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Wayzek Science, St Paul, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"2025121401262870000_14.9.e081628.1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025121401262870000_14.9.e081628.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07119.x"},{"key":"2025121401262870000_14.9.e081628.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2014.05.001"},{"key":"2025121401262870000_14.9.e081628.4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/clc.22659","article-title":"Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review","volume":"40","author":"Owens","year":"2017","journal-title":"Clin Cardiol"},{"key":"2025121401262870000_14.9.e081628.5","article-title":"Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease","volume":"11","author":"Kimachi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121401262870000_14.9.e081628.6","article-title":"Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: A systematic review and meta-analysis","volume":"77","author":"Almas","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"key":"2025121401262870000_14.9.e081628.7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/phar.1884","article-title":"Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know","volume":"37","author":"Conway","year":"2017","journal-title":"Pharmacotherapy"},{"key":"2025121401262870000_14.9.e081628.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.01.011"},{"key":"2025121401262870000_14.9.e081628.9","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830"},{"key":"2025121401262870000_14.9.e081628.10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/rth2.12157","article-title":"Barriers to integrating direct oral anticoagulants into anticoagulation clinic care: A mixed-methods study","volume":"3","author":"Barnes","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"2025121401262870000_14.9.e081628.11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.18433\/J30W4F","article-title":"Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation","volume":"20","author":"Brais","year":"2017","journal-title":"J Pharm Pharm Sci"},{"key":"2025121401262870000_14.9.e081628.12","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2350"},{"key":"2025121401262870000_14.9.e081628.13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10840-022-01274-1","article-title":"Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database","volume":"66","author":"Munir","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"2025121401262870000_14.9.e081628.14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/2042098618774498","article-title":"Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis","volume":"9","author":"Fava","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"2025121401262870000_14.9.e081628.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198674","article-title":"Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the \u201crubber effect.\u201d","volume":"13","author":"Ziakas","year":"2018","journal-title":"PLoS One"},{"key":"2025121401262870000_14.9.e081628.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37288","article-title":"Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries","volume":"4","author":"Wheelock","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025121401262870000_14.9.e081628.17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.amjms.2023.01.004","article-title":"Direct oral anticoagulants and warfarin safety in rural patients with obesity","volume":"365","author":"Caverley","year":"2023","journal-title":"Am J Med Sci"},{"key":"2025121401262870000_14.9.e081628.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajmo.2022.100026","article-title":"Oral anticoagulation use in non-valvular atrial fibrillation patients in rural setting","volume":"9","author":"Brod","year":"2023","journal-title":"Am J Med Open"},{"key":"2025121401262870000_14.9.e081628.19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40256-021-00502-9","article-title":"Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries","volume":"22","author":"Norby","year":"2022","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025121401262870000_14.9.e081628.20","unstructured":"Centers for Medicare & Medicaid Services . Data from 2020 medicare part d prescribers - by provider public use file. n.d. Available: https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/medicare-part-d-prescribers-by-provider\/data\/2020"},{"key":"2025121401262870000_14.9.e081628.21","unstructured":"Centers for Medicare & Medicaid Services . Data from 2020 medicare part d prescribers - by provider and drug public use file. n.d. Available: https:\/\/data.cms.gov\/provider-summary-by-type-of-service\/medicare-part-d-prescribers\/medicare-part-d-prescribers-by-provider-and-drug\/data\/2020"},{"key":"2025121401262870000_14.9.e081628.22","unstructured":"Centers for Medicare & Medicaid Services . Medicare Part D Prescribers Methodology, Available: https:\/\/data.cms.gov\/resources\/medicare-part-d-prescribers-methodology"},{"key":"2025121401262870000_14.9.e081628.23","unstructured":"United States Census Bureau . Census Regions and Divisions of the United States, Available: https:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf"},{"key":"2025121401262870000_14.9.e081628.24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10006-021-01033-y","article-title":"Do rural oral and maxillofacial surgeons prescribe more postoperative opioids?","volume":"26","author":"Harris","year":"2022","journal-title":"Oral Maxillofac Surg"},{"key":"2025121401262870000_14.9.e081628.25","unstructured":"Centers for Medicare & Medicaid Services . 2011 report: evaluation of the cms-hcc risk adjustment model. n.d. Available: https:\/\/www.cms.gov\/Medicare\/Health-Plans\/MedicareAdvtgSpecRateStats\/Risk-Adjustors-Items\/Evaluation2011"},{"key":"2025121401262870000_14.9.e081628.26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048086","article-title":"Temporal trends in the association of social vulnerability and race\/ethnicity with county-level COVID-19 incidence and outcomes in the USA: an ecological analysis","volume":"11","author":"Islam","year":"2021","journal-title":"BMJ Open"},{"key":"2025121401262870000_14.9.e081628.27","doi-asserted-by":"crossref","unstructured":"Waller LA , Gotway CA . Applied spatial statistics for public health data. John Wiley & Sons, Inc, 2004.","DOI":"10.1002\/0471662682"},{"key":"2025121401262870000_14.9.e081628.28","doi-asserted-by":"crossref","unstructured":"Besag J , York J , Molli\u00e9 A . Bayesian image restoration, with two applications in spatial statistics. Annals of the Institute of Statistical Mathematics. 1991;43:1\u201320. doi:10.1007\/BF00116466","DOI":"10.1007\/BF00116466"},{"key":"2025121401262870000_14.9.e081628.29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","article-title":"Approximate Bayesian Inference for Latent Gaussian models by using Integrated Nested Laplace Approximations","volume":"71","author":"Rue","year":"2009","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2025121401262870000_14.9.e081628.30","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v063.i18"},{"key":"2025121401262870000_14.9.e081628.31","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.joms.2021.10.018","article-title":"Do Patterns of Opioid Prescriptions to Medicare Beneficiaries Differ Between Oral and Maxillofacial Surgeons Practicing in Urban and Rural Settings?","volume":"80","author":"Wang","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"key":"2025121401262870000_14.9.e081628.32","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182010993","article-title":"Gender and Socioeconomic Inequality in the Prescription of Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation in Primary Care in Catalonia (Fantas-TIC Study)","volume":"18","author":"Dalmau Llorca","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025121401262870000_14.9.e081628.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022065","article-title":"Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals","volume":"8","author":"Bungard","year":"2018","journal-title":"BMJ Open"},{"key":"2025121401262870000_14.9.e081628.34","unstructured":"Tarazi W , Finegold K , Sheingold S , et al . Prescription Drug Affordability among Medicare Beneficiaries (Issue Brief no.HP-2022-03). Office of the Assistant Secretary for Planning and Evaluation, U.S Department of Health and Human Services. 2022. Available: https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/1e2879846aa54939c56efeec9c6f96f0\/prescription-drug-affordability.pdf"},{"key":"2025121401262870000_14.9.e081628.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"key":"2025121401262870000_14.9.e081628.36","first-page":"1056","article-title":"Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees","volume":"27","author":"Wong","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"2025121401262870000_14.9.e081628.37","unstructured":"Centers for Disease Control and Prevention . Interactive Atlas of Heart Disease and Stroke, Available: https:\/\/nccd.cdc.gov\/DHDSPAtlas\/?state=County"},{"key":"2025121401262870000_14.9.e081628.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-2091-0","article-title":"Regional variation in antibiotic prescribing among medicare part D enrollees, 2013","volume":"16","author":"Arizpe","year":"2016","journal-title":"BMC Infect Dis"},{"key":"2025121401262870000_14.9.e081628.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-022-02971-2","article-title":"Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers","volume":"22","author":"Toth","year":"2022","journal-title":"BMC Geriatr"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T09:26:42Z","timestamp":1765704402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9,25]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjopen-2023-081628"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081628","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}